Rigel Pharmaceuticals | RIGL - Modal Saham Biasa





Modal Saham Biasa Perubahan Tanggal
Agenus USD 38.52M 3.2M 2026-03
Amgen USD 541M 0 2026-09
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 141.14M 564K 2026-06
AstraZeneca USD 1.55B 28K 2026-09
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Celldex Therapeutics USD 78.53M 34K 2026-09
Daiichi Sankyo JPY 1.82B 1.68M 2026-09
Eli Lilly USD 943.5M 3.33M 2026-03
Halozyme Therapeutics USD 113.94M 106K 2026-09
Heron Therapeutics USD 188.31M 4.99M 2025-12
Intrexon USD 0 0 2024-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
MacroGenics USD 63.65M 86K 2026-06
Neurocrine Biosciences USD 101.3M 750K 2026-09
Pfizer USD 5.7B 0 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Rigel Pharmaceuticals USD 17K 158K 2024-06
Ultragenyx Pharmaceutical USD 98.6M 300K 2026-06
Veracyte USD 80.39M 598K 2026-09